EGFR Regulates the Hippo pathway by promoting the tyrosine phosphorylation of MOB1
Ando et al show in head and neck squamous cell carcinoma cells that EGFR activation leads to the phosphorylation of the Hippo pathway component, MOB1 to inhibit LATS1/2 function resulting in YAP/TAZ activation. Further, EGFR-targeting therapies suppress YAP/TAZ, and loss of LATS1/2-mediated YAP/TAZ...
Guardado en:
Autores principales: | Toshinori Ando, Nadia Arang, Zhiyong Wang, Daniela Elena Costea, Xiaodong Feng, Yusuke Goto, Hiroki Izumi, Mara Gilardi, Kazuyo Ando, J. Silvio Gutkind |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/33b5d7dcaf814e90908b2ebbb399a0ea |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Stable MOB1 interaction with Hippo/MST is not essential for development and tissue growth control
por: Yavuz Kulaberoglu, et al.
Publicado: (2017) -
Par-1 regulates tissue growth by influencing hippo phosphorylation status and hippo-salvador association.
por: Hong-Ling Huang, et al.
Publicado: (2013) -
EGFR-dependent tyrosine phosphorylation of integrin β4 is not required for downstream signaling events in cancer cell lines
por: Lisa te Molder, et al.
Publicado: (2021) -
Assembly and activation of the Hippo signalome by FAT1 tumor suppressor
por: Daniel Martin, et al.
Publicado: (2018) -
Targeted Quantification of Phosphorylation Sites Identifies STRIPAK-Dependent Phosphorylation of the Hippo Pathway-Related Kinase SmKIN3
por: Valentina Stein, et al.
Publicado: (2021)